Literature DB >> 2285023

Copper and aspirin treatment increase the antioxidant activity of plasma.

M C McGahan1.   

Abstract

Copper (Cu) complexes of a number of compounds have increased anti-inflammatory efficacy over the native compound. In the present study, Cu and acetylsalicylic acid (ASA) were administered to rabbits over a one week period. At the end of this time, ocular inflammation was induced by intravitreal injection of endotoxin. ASA caused a slight reduction in the inflammatory response at 24 hours, but this response was not further decreased when Cu was added to the treatment regimen. However, there was a gradual and significant increase in antioxidant activity in the plasma of animals in the combined treatment group which could not be accounted for by a Cu-ASA complex, an increase in the concentration of known plasma protein antioxidants (ceruloplasmin and transferrin) or an increase in superoxide dismutase activity. The compound(s) responsible for this increased activity has a molecular weight greater than 10,000 Da. A large increase in plasma antioxidant activity may have a protective effect in other models of inflammation and provide a mechanism for the proven increase in anti-inflammatory efficacy of Cu-chelates of many compounds.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2285023     DOI: 10.1007/bf02003222

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  23 in total

1.  A rapid colorimetric method for the quantitative determination of copper oxidase activity (ceruloplasmin).

Authors:  O B HOUCHIN
Journal:  Clin Chem       Date:  1958-12       Impact factor: 8.327

2.  Some copper coordination compounds and their antiinflammatory and antiulcer activities.

Authors:  J R Sorenson
Journal:  Inflammation       Date:  1976-06       Impact factor: 4.092

3.  Ferroxidase activity increases in the aqueous humor during the ocular inflammatory response.

Authors:  M C McGahan; A M Grimes; L N Fleisher
Journal:  Ophthalmic Res       Date:  1989       Impact factor: 2.892

4.  Copper complexes: a physiologic approach to treatment of chronic diseases.

Authors:  J R Sorenson
Journal:  Compr Ther       Date:  1985-04

5.  Oxidation of salicylates by stimulated granulocytes: evidence that these drugs act as free radical scavengers in biological systems.

Authors:  A L Sagone; R M Husney
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

6.  Time course for prostaglandin synthesis by rabbit lens during endotoxin-induced ocular inflammation.

Authors:  L N Fleisher; M C McGahan
Journal:  Curr Eye Res       Date:  1986-09       Impact factor: 2.424

7.  The inhibition of lipid autoxidation by human caeruloplasmin.

Authors:  D J Al-Timimi; T L Dormandy
Journal:  Biochem J       Date:  1977-11-15       Impact factor: 3.857

8.  Effects of copper deficiency on carbon tetrachloride-induced lipid peroxidation.

Authors:  R A Lawrence; S G Jenkinson
Journal:  J Lab Clin Med       Date:  1987-02

9.  Antioxidant activity of aqueous and vitreous humor from the inflamed rabbit eye.

Authors:  M C McGahan; L N Fleisher
Journal:  Curr Eye Res       Date:  1986-09       Impact factor: 2.424

10.  Copper and ceruloplasmin (Cp) concentrations during the acute inflammatory process in the rat.

Authors:  A Conforti; L Franco; R Milanino; G P Velo
Journal:  Agents Actions       Date:  1982-07
View more
  3 in total

Review 1.  Copper and zinc body levels in inflammation: an overview of the data obtained from animal and human studies.

Authors:  R Milanino; M Marrella; R Gasperini; M Pasqualicchio; G Velo
Journal:  Agents Actions       Date:  1993-07

2.  Piroxicam-copper complexes: inhibition of polymorphonuclear leukocyte migration to Pseudomonas aeruginosa chemotactins in vivo and superoxide dismutase-like activity in vitro.

Authors:  D O Sordelli; P A Fontán; C R Amura
Journal:  Agents Actions       Date:  1993-03

3.  Effects of copper depletion and D-penicillamine treatment on the ocular inflammatory response.

Authors:  M C McGahan; L N Fleisher; A M Grimes
Journal:  Agents Actions       Date:  1991-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.